Reducing vancomycin use utilizing a computer guideline: Results of a randomized controlled trial

Journal of the American Medical Informatics Association

Volumn 5, Issue 6, 1998, Pages 554-562

  Shojania, Kaveh G ^a   Yokoe, Deborah ^a   Platt, Richard ^a   Fiskio, Julie ^a   Ma'luf, Nell ^a   Bates, David W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ARTICLE; CLINICAL TRIAL; COMPUTER SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL;

EID: 0031743091     PISSN: 10675027     EISSN: None     Source Type: Journal    
DOI: 10.1136/jamia.1998.0050554     Document Type: Article

References (29)

1. Uttlely AC, Collins CH, Naidoo J, George RC. Vancomycin resistant enterococci. Lancet. 1988;1(8575-6):57-8.
2. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319(3):157-61.
3. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet. 1993;342(8863):76-9.
4. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med. 1995;123(4):250-9.
5. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993;42(30):597-99.
6. Lai KK. Treatment of vancomycion-resistant Enterococcus faecium infections. Arch Intern Med. 1996;156(22):2579-84.
7. Noble WC, Virani Z, Cree R. Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992;72(2): 195-8.
8. Reduced Susceptibility of Staphylococcus aureus to vancomycin - Japan 1996. MMWR Morb Mortal Wkly Rep. 1997;46(27):624-6.
9. Staphylococcus aureus with reduced susceptibility to vancomycin - United States 1997. MMWR Morb Mortal Wkly Rep. 1997;46(33):765-6.
10. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practises Advisory Committee (HICPAC). MMWR Rec Rep 1995;44(RR-12):1-13. Am J Infect Control 1995;23(2): 87-94. Infect Control Hosp Epidemiol 1992;16(2):105-12.
11. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practises Advisory Committee (HICPAC). MMWR Rec Rep 1995;44(RR-12):1-13. Am J Infect Control 1995;23(2): 87-94. Infect Control Hosp Epidemiol 1992;16(2):105-12.
12. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practises Advisory Committee (HICPAC). MMWR Rec Rep 1995;44(RR-12):1-13. Am J Infect Control 1995;23(2): 87-94. Infect Control Hosp Epidemiol 1992;16(2):105-12.
13. Kunin CM, Tupasi T, Craig WA. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Ann Intern Med. 1973;79(4):555-60.
14. Craig WA, Umar SJ, Shaw WR, Ramgopal V, Eagan LL, Leopold ET. Hospital use of antimicrobial drugs: survey of 19 hospitals and results of antimicrobial control problems. Ann Intern Med. 1978;89(Pt 5, Suppl 2):793-5.
15. Soumerai SB, Avorn J, Taylor WC, Wessels M, Maher D, Hawley SL. Improving choice of prescribed antibiotics through concurrent reminders in an educational order form. Med Care. 1993;31:552-8.
16. Soumerai SB, Avorn JA. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA. 1990;263(4):549-56.
17. Corder MP. Modification of physician behavior by performance feedback. Physician Exec. 1996;22(4):26-8.
18. Davis DA, Thompson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995; 274(9):700-5.
19. Quale J, Landman D, Atwood E, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control. 1996;24(5):372-9.
20. Sittig DF, Stead WW. Computer-based physician order entry: the state of the art. J Am Med Inform Assoc. 1994;1(2): 108-23.
21. Tierney WM, Miller ME, Overhage JM, McDonald CJ. Physician inpatient order writing on microcomputer workstations: effect on resource utilization. JAMA. 1993;269(3): 379-83.
22. Bates DW, Kuperman G, Teich JM. Computerized physician order entry and quality of care. Qual Manage in Health Care. 1994;2(4):18-27.
23. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA. 1993;269(5):598-602.
24. Gillings D, Makuc D, Siegel E. Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health. 1981;71(1):38-46.
25. Harpole LH, Khorasani R, Fiskio J, Kuperman GJ, Bates DW. Automated evidence-based critiquing of orders for abdominal radiographs: impact on utilization and appropriateness. J Am Med Inform Assoc. 1997;4(6):511-21.
26. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med. 1996:124(10):884-90.
27. Evans RS, Pestotnik SL, Classen DC, et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med. 1998;338(4):232-8.
28. Anglim AM, Klym B, Byers KE, Scheld WM, Farr BM. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med. 1997;157(10):1132-6.
29. Lobach DF, Hammond WE. Computerized decision support based on a clinical practice guideline improves compliance with care standards. Am J Med. 1997;102(1):89-98.